Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 17/20 | 0.49 |
| ▸ | CYP17A1 | P05093 | 8/20 | 0.49 |
| ▸ | SCN1A | P35498 | 1/20 | 0.41 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.41 |
| ▸ | SCN3A | Q9NY46 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17213209 | 1.00 | CYP19A1 (0.49) | CYP19A1CYP17A1SCN1ASCN2ASCN3A | |
| SCHEMBL20349637 | 0.88 | CYP19A1 (0.39) | CYP19A1CYP17A1SCN1ASCN2ASCN3A | |
| SCHEMBL11195088 | 0.83 | CYP19A1 (0.53) | CYP19A1CYP17A1SCN1ASCN2ASCN3A | |
| SCHEMBL13486938 | 0.79 | RET (0.32) | CYP19A1CYP17A1 | |
| SCHEMBL1439686 | 0.79 | CYP19A1 (0.50) | CYP19A1CYP17A1SCN1ASCN2ASCN3A | |
| SCHEMBL23633732 | 0.78 | ALDH1A1 (0.31) | CYP19A1CYP17A1 | |
| SCHEMBL4597731 | 0.78 | CYP19A1 (0.49) | CYP19A1CYP17A1SCN1ASCN2ASCN3A | |
| SCHEMBL17213197 | 0.78 | CYP19A1 (0.49) | CYP19A1CYP17A1SCN1ASCN2ASCN3A | |
| SCHEMBL23633727 | 0.78 | ALDH1A1 (0.32) | — | |
| SCHEMBL9065373 | 0.77 | CYP19A1 (0.39) | CYP19A1CYP17A1SCN1ASCN2ASCN3A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0059528-B1 | POLYSILOXANE WITH POLYCYCLIC MODIFIER COMPOSITION AND BIOMEDICAL DEVICES | BAUSCH & LOMB INCORPORATED (US) | 1986-04-16 | — | — | EP | claimed |
| US-20170044282-A1 | TERPENE AND TERPENOID DERIVATIVES CONTAINING VINYL GROUPS FOR THE PREPARATION OF POLYMERS | THE UNIVERSITY OF NOTTINGHAM (GB) | 2017-02-16 | — | — | US | disclosed |
| EP-1877856-A1 | PHOTOCHROMIC BLUE LIGHT FILTERING MATERIALS AND OPHTHALMIC DEVICES | Bausch & Lomb Incorporated (US) | 2008-01-16 | — | — | EP | disclosed |
| US-20070159594-A9 | Photochromic blue light filtering materials and ophthalmic devices | BAUSCH & LOMB INCORPORATED | 2007-07-12 | — | — | US | disclosed |
| WO-2006119328-A1 | PHOTOCHROMIC BLUE LIGHT FILTERING MATERIALS AND OPHTHALMIC DEVICES | BAUSCH & LOMB INCORPORATED (US) | 2006-11-09 | — | — | WO | disclosed |
| US-20050254003-A1 | Photochromic blue light filtering materials and ophthalmic devices | BAUSCH & LOMB INCORPORATED | 2005-11-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170044282-A1 | TERPENE AND TERPENOID DERIVATIVES CONTAINING VINYL GROUPS FOR THE PREPARATION OF POLYMERS | GGPS1, DHPS, FDPS | CYP19A1 99/4885CYP17A1 16/4885SCN1A 4782/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.